Literature DB >> 2002558

Immunoglobulin A mediation of murine nasal anti-influenza virus immunity.

K B Renegar1, P A Small.   

Abstract

Most mice which have recovered from influenza virus infection are immune to reinfection with the same influenza virus. This immunity could be abrogated by the intranasal instillation of anti-immunoglobulin A (anti-IgA) but not of anti-IgG or anti-IgM antiserum. Thus, IgA is the major, if not the sole, mediator of nasal immunity to influenza virus in immunocompetent mice.

Entities:  

Mesh：

Substances：

Year:  1991        PMID： 2002558      PMCID： PMC240095     

Source DB:  PubMed          Journal:  J Virol        ISSN： 0022-538X            Impact factor:   5.103


  16 in total

1.  Observations on excess mortality associated with epidemic influenza.

Authors:  T C EICKHOFF; I L SHERMAN; R E SERFLING
Journal:  JAMA       Date:  1961-06-03       Impact factor: 56.272

2.  Serum and nasal wash antibodies associated with resistance to experimental challenge with influenza A wild-type virus.

Authors:  M L Clements; R F Betts; E L Tierney; B R Murphy
Journal:  J Clin Microbiol       Date:  1986-07       Impact factor: 5.948

3.  Systemic immunization with pneumococcal polysaccharide vaccine induces a predominant IgA2 response of peripheral blood lymphocytes and increases of both serum and secretory anti-pneumococcal antibodies.

Authors:  C Lue; A Tarkowski; J Mestecky
Journal:  J Immunol       Date:  1988-06-01       Impact factor: 5.422

4.  Protective effect of antibody to parainfluenza type 1 virus.

Authors:  C B Smith; R H Purcell; J A Bellanti; R M Chanock
Journal:  N Engl J Med       Date:  1966-11-24       Impact factor: 91.245

5.  The swine-influenza decision.

Authors:  S C Schoenbaum; B J McNeil; J Kavet
Journal:  N Engl J Med       Date:  1976-09-30       Impact factor: 91.245

6.  Passive transfer of local immunity to influenza virus infection by IgA antibody.

Authors:  K B Renegar; P A Small
Journal:  J Immunol       Date:  1991-03-15       Impact factor: 5.422

7.  Enhanced murine respiratory tract IgA antibody response to oral influenza vaccine when combined with a lipoidal amine (avridine).

Authors:  K C Bergmann; R H Waldman
Journal:  Int Arch Allergy Appl Immunol       Date:  1988

8.  Subclass distribution and molecular form of immunoglobulin A hemagglutinin antibodies in sera and nasal secretions after experimental secondary infection with influenza A virus in humans.

Authors:  T A Brown; B R Murphy; J Radl; J J Haaijman; J Mestecky
Journal:  J Clin Microbiol       Date:  1985-08       Impact factor: 5.948

9.  Analysis of immunoglobulin G antibody responses after administration of live and inactivated influenza A vaccine indicates that nasal wash immunoglobulin G is a transudate from serum.

Authors:  D K Wagner; M L Clements; C B Reimer; M Snyder; D L Nelson; B R Murphy
Journal:  J Clin Microbiol       Date:  1987-03       Impact factor: 5.948

10.  CHARACTERISTICS OF AN IMMUNE SYSTEM COMMON TO CERTAIN EXTERNAL SECRETIONS.

Authors:  T B TOMASI; E M TAN; A SOLOMON; R A PRENDERGAST
Journal:  J Exp Med       Date:  1965-01-01       Impact factor: 14.307
View more
  55 in total

1.  Nasal-associated lymphoid tissue is a site of long-term virus-specific antibody production following respiratory virus infection of mice.

Authors:  B Liang; L Hyland; S Hou
Journal:  J Virol       Date:  2001-06       Impact factor: 5.103

2.  Route of nutrition influences generation of antibody-forming cells and initial defense to an active viral infection in the upper respiratory tract.

Authors:  Cheryl D Johnson; Kenneth A Kudsk; Kazuhiko Fukatsu; Kathryn B Renegar; Ben L Zarzaur
Journal:  Ann Surg       Date:  2003-04       Impact factor: 12.969

3.  Intracellular neutralization of virus by immunoglobulin A antibodies.

Authors:  M B Mazanec; C S Kaetzel; M E Lamm; D Fletcher; J G Nedrud
Journal:  Proc Natl Acad Sci U S A       Date:  1992-08-01       Impact factor: 11.205

Review 4.  Mucosal immunity: overcoming the barrier for induction of proximal responses.

Authors:  Brent S McKenzie; Jamie L Brady; Andrew M Lew
Journal:  Immunol Res       Date:  2004       Impact factor: 2.829

Review 5.  Epithelial crosstalk at the microbiota-mucosal interface.

Authors:  Jerry M Wells; Oriana Rossi; Marjolein Meijerink; Peter van Baarlen
Journal:  Proc Natl Acad Sci U S A       Date:  2010-09-08       Impact factor: 11.205

6.  Bombesin recovers gut-associated lymphoid tissue and preserves immunity to bacterial pneumonia in mice receiving total parenteral nutrition.

Authors:  R C DeWitt; Y Wu; K B Renegar; B K King; J Li; K A Kudsk
Journal:  Ann Surg       Date:  2000-01       Impact factor: 12.969

7.  Mucosally induced immunoglobulin E-associated inflammation in the respiratory tract.

Authors:  J W Simecka; R J Jackson; H Kiyono; J R McGhee
Journal:  Infect Immun       Date:  2000-02       Impact factor: 3.441

8.  Live attenuated influenza virus expressing human interleukin-2 reveals increased immunogenic potential in young and aged hosts.

Authors:  Boris Ferko; Christian Kittel; Julia Romanova; Sabine Sereinig; Hermann Katinger; Andrej Egorov
Journal:  J Virol       Date:  2006-09-13       Impact factor: 5.103

9.  Mucosal model of immunization against human immunodeficiency virus type 1 with a chimeric influenza virus.

Authors:  T Muster; B Ferko; A Klima; M Purtscher; A Trkola; P Schulz; A Grassauer; O G Engelhardt; A García-Sástre; P Palese
Journal:  J Virol       Date:  1995-11       Impact factor: 5.103

10.  Sublingual administration of bacteria-expressed influenza virus hemagglutinin 1 (HA1) induces protection against infection with 2009 pandemic H1N1 influenza virus.

Authors:  Byoung-Shik Shim; Jung-Ah Choi; Ho-Hyun Song; Sung-Moo Park; In Su Cheon; Ji-Eun Jang; Sun Je Woo; Chung Hwan Cho; Min-Suk Song; Hyemi Kim; Kyung Joo Song; Jae Myun Lee; Suhng Wook Kim; Dae Sub Song; Young Ki Choi; Jae-Ouk Kim; Huan Huu Nguyen; Dong Wook Kim; Young Yil Bahk; Cheol-Heui Yun; Man Ki Song
Journal:  J Microbiol       Date:  2013-03-02       Impact factor: 3.422
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.